MFIM
NEO icon

Mesirow Financial Investment Management’s NeoGenomics NEO Stock Holding History

Mesirow Financial Investment Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-44,385
Closed -$362K – 62
2018
Q1 		$362K Buy
44,385
+12,551
+39% +$102K 1.52% 33
2017
Q4 		$282K Buy
31,834
+566
+2% +$5.22K 1.28% 47
2017
Q3 		$348K Sell
31,268
-41,353
-57% -$402K 1.64% 34
2017
Q2 		$651K Buy
+72,621
New +$576K 3.08% 1

Other funds holding NEO

GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Mesirow Financial Investment Management's NEO Position: Q2 2018 in Review

Mesirow Financial Investment Management sold out of NeoGenomics (NEO) in Q2 2018, closing a stake of 44,385 shares — an estimated $362K sold.

Mesirow Financial Investment Management first reported a position in NEO in Q2 2017 and held it in 4 quarters. The position peaked at $651K in Q2 2017. 148 funds tracked by Wall St. Rank hold NEO as of Q2 2018.

  • Mesirow Financial Investment Management reported no remaining NeoGenomics position as of Q2 2018 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 44,385 NeoGenomics shares in Q2 2018, an estimated $362K.
  • Mesirow Financial Investment Management first reported a position in NeoGenomics in Q2 2017 and held it in 4 quarters.
  • Mesirow Financial Investment Management's NeoGenomics position peaked at $651K in Q2 2017.
  • 148 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2018.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2018, filed 11 Jul 2018.